ArticleACS applied nano materials2025
Graphene Oxide-Functionalized Optical Sensor for Label-Free Detection of Breast Cancer Cells.
Article in ACS applied nano materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Interfacial Redox-Driven Crystallization on MXene Enables Ultrasensitive HgACS applied materials & interfaces · 2026Article
- Functionalization Techniques Empowering Optical Fiber Biosensors in Label-Free Cancer Biomarker Detection.Biosensors · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate and noninvasive detection of cancer cells is critical for advancing early stage cancer diagnostics and monitoring tumor progression. While manual enumeration methods, such as hemocytometry, remain in use, they suffer from limited sensitivity and scalability. In this article, we report the first feasibility study demonstrating a graphene oxide (GO)-functionalized long-period fiber grating (LPG) sensor for the label-free detection of MCF-7 human breast cancer cell density via secreted cellular byproducts. The sensing mechanism is based on refractive index (RI) modulation in the culture medium, where the GO overlay serves as a functional interface to enhance light-matter interaction and mode coupling between the LPG device and the external medium. GO nanocoatings were deposited on the device surface via an in situ layer-by-layer (i-LbL) assembly method and characterized using scanning electron microscopy (SEM), atomic force microscopy (AFM), and Raman spectroscopy. Furthermore, by precisely controlling the thickness of the GO nanocoating, we experimentally investigated the impact of the GO thickness on the optical properties, revealing distinct thickness-dependent behavior. Resonance changes correlated clearly with metabolite accumulation, thus enabling indirect detection of cancer cell density. The GO-LPG sensor demonstrated detection of MCF-7 cell densities ranging from 0 to 1 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.